Sapan Shah, PhD
Chief Executive Officer, Glyscend Therapeutics
Dr. Shah joined Glyscend Therapeutics as Chief Executive Officer in September 2023. He has 25+ years experience building, financing and operating innovative companies advancing novel therapeutics that address critical areas of unmet medical need. Previous CEO roles have included StrideBio, ARMGO Pharma, Ezose Sciences, and Shionogi Inc. Dr. Shah began his career as a consultant with McKinsey & Company and holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University and B.A. degrees in Mathematics, Biochemistry and Integrated Science from Northwestern University.